134 related articles for article (PubMed ID: 20842029)
21. [Not Available].
Vialon M; Desailloud R; Caron P
Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S19-S28. PubMed ID: 31606058
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1. I. Diagnosis].
Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2004 Mar; 129(12):630-3. PubMed ID: 15011133
[No Abstract] [Full Text] [Related]
24. Improvement in the care of multiple endocrine neoplasia type 1 through a regional multidisciplinary clinic.
White HD; Blair J; Pinkney J; Cuthbertson DJ; Day R; Weber A; MacFarlane IA
QJM; 2010 May; 103(5):337-45. PubMed ID: 20231234
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
[TBL] [Abstract][Full Text] [Related]
26. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
27. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
29. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
30. [Screening for hereditary neuroendocrine tumors of the gastrointestinal-pancreatic system].
Scherübl H; Bredeek U; Zimmer T; Riecken EO
Z Gastroenterol; 1996 Apr; 34(4):XX. PubMed ID: 8686345
[No Abstract] [Full Text] [Related]
31. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P
Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021
[TBL] [Abstract][Full Text] [Related]
32. Genetic risk assessment, counseling and testing.
Rich TA; Salazar M
Surg Oncol Clin N Am; 2009 Jan; 18(1):19-38, vii. PubMed ID: 19056040
[TBL] [Abstract][Full Text] [Related]
33. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
34. [Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes].
Sarkadi B; Grolmusz VK; Butz H; Kövesdi A; Likó I; Nyirő G; Igaz P; Patócs A
Orv Hetil; 2018 Feb; 159(7):285-292. PubMed ID: 29429353
[TBL] [Abstract][Full Text] [Related]
35. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
36. The role of genetics in pediatric endocrinology.
Potter A; Hannig V; Phillips JA
Pediatr Endocrinol Rev; 2004 Mar; 1(3):262-73. PubMed ID: 16437020
[TBL] [Abstract][Full Text] [Related]
37. A germline mutation in a Thai family with familial multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Shotelersuk V; Sirisalipoch S; Nonthasoot B; Sirichindakul B; Wisedopas N; Suwanwalaikorn S
J Med Assoc Thai; 2005 Feb; 88(2):191-5. PubMed ID: 15962670
[TBL] [Abstract][Full Text] [Related]
38. Practical aspects of delivering hereditary cancer risk counseling.
DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
[TBL] [Abstract][Full Text] [Related]
39. [Multiple endocrine neoplasia type 1: genetic and clinical aspects].
Calender A; Cadiot G; Mignon M
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B38-48. PubMed ID: 11449144
[No Abstract] [Full Text] [Related]
40. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
